Anthill has strong interest in investing in, and advising, early stage companies in areas like early cancer detection, cancer cure using next-gen technologies like Genomics sequencing and CRISPR, holistic health with Ayurveda and other alternatives, and adjacencies like wound and trauma management.
Our partnerships with HCG, and numerous other premier Healthcare providers enable us to provide tremendously useful advisors, access to mentors, and business development opportunities – all designed to precipitate rapid growth!
Anthill gives a wonderful pulse into the health tech startups ecosystem globally. Aligning with them has helped us discover and interact with numerous early stage companies with high pedigree and strong IP. The solutions from these companies often complement our offerings and as such, are a great benefit to HCG